obicetrapib 10 mg + ezetimibe 10 mg FDC daily

2 treatments and conditions followed through the public trial records. Not medical advice. How a status is set

Treatments and conditions

obicetrapib 10 mg + ezetimibe 10 mg FDC daily
Treatment and conditionWhere it standsTrials
obicetrapib 10 mg + ezetimibe 10 mg FDC daily for coronary artery diseasePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
obicetrapib 10 mg + ezetimibe 10 mg FDC daily for hyperlipidemiasPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1